Submitted by Anonymous (not verified) on 10 March 2025 - 16:01
Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised